Yamashita Health Care Holdings,Inc.

TSE:9265 Stock Report

Market Cap: JP¥6.0b

Yamashita Health Care HoldingsInc Past Earnings Performance

Past criteria checks 4/6

Yamashita Health Care HoldingsInc has been growing earnings at an average annual rate of 2.4%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 2.4% per year. Yamashita Health Care HoldingsInc's return on equity is 5.9%, and it has net margins of 0.8%.

Key information

2.4%

Earnings growth rate

2.4%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate-2.4%
Return on equity5.9%
Net Margin0.8%
Next Earnings Update14 Jan 2025

Recent past performance updates

We Think Yamashita Health Care HoldingsInc's (TSE:9265) Profit Is Only A Baseline For What They Can Achieve

Jul 19
We Think Yamashita Health Care HoldingsInc's (TSE:9265) Profit Is Only A Baseline For What They Can Achieve

Recent updates

Little Excitement Around Yamashita Health Care Holdings,Inc.'s (TSE:9265) Earnings As Shares Take 25% Pounding

Oct 31
Little Excitement Around Yamashita Health Care Holdings,Inc.'s (TSE:9265) Earnings As Shares Take 25% Pounding

We Think Yamashita Health Care HoldingsInc's (TSE:9265) Profit Is Only A Baseline For What They Can Achieve

Jul 19
We Think Yamashita Health Care HoldingsInc's (TSE:9265) Profit Is Only A Baseline For What They Can Achieve

Revenue & Expenses Breakdown

How Yamashita Health Care HoldingsInc makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:9265 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 2462,7175017,4680
31 May 2461,5555807,2790
29 Feb 2461,8436607,0990
30 Nov 2359,4339006,8290
31 Aug 2358,7452166,7280
31 May 2358,1952196,7050
28 Feb 2356,2341056,7670
30 Nov 2255,471246,7260
31 Aug 2255,7317176,6620
31 May 2255,1456966,5870
28 Feb 2260,9847746,4640
30 Nov 2164,9648416,4410
31 Aug 2167,4887726,3890
31 May 2170,1316786,3570
28 Feb 2166,4955576,1150
30 Nov 2064,0683546,1030
31 Aug 2064,2064236,1020
31 May 2064,6584596,0650
29 Feb 2065,1053995,9290
30 Nov 1965,2384705,7930
31 Aug 1963,2372935,7670
31 May 1961,5331445,7840
28 Feb 1961,5144205,6960
30 Nov 1860,4512885,7330
31 Aug 1859,4122425,7440
31 May 1858,6922205,7370
28 Feb 1856,9651035,7130
30 Nov 1755,806305,5800
31 Aug 1754,205-365,5100
31 May 1752,517195,3940
28 Feb 1751,933135,3950
30 Nov 1651,4312065,3580
31 Aug 1652,0133025,2380
31 May 1651,6153325,2160
29 Feb 1652,0073765,2700
30 Nov 1551,5963675,2480
31 Aug 1551,1983775,2420
31 May 1550,3103595,1730
28 Feb 1549,7123545,2150
30 Nov 1450,6593975,2480
31 Aug 1450,0844425,2390
31 May 1451,0495535,2200
28 Feb 1450,1504825,1040

Quality Earnings: 9265 has a large one-off loss of ¥207.0M impacting its last 12 months of financial results to 31st August, 2024.

Growing Profit Margin: 9265's current net profit margins (0.8%) are higher than last year (0.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9265's earnings have grown by 2.4% per year over the past 5 years.

Accelerating Growth: 9265's earnings growth over the past year (131.9%) exceeds its 5-year average (2.4% per year).

Earnings vs Industry: 9265 earnings growth over the past year (131.9%) exceeded the Healthcare industry 8.3%.


Return on Equity

High ROE: 9265's Return on Equity (5.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 16:53
End of Day Share Price 2024/12/25 00:00
Earnings2024/08/31
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yamashita Health Care Holdings,Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution